Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features Overcomes the blood-brain barrier using advanced delivery methods Improves drug penetration & specificity with nano and polymer-based systems Explores new therapies through immunotherapy, gene therapy, and personalised medicine Builds preclinical models & identifies biomarkers to support clinical success Designs regulatory-aligned clinical trial strategies for faster translation

Handbook of Practical Pharmacology – I serves as a vital bridge between theoretical pharmacology and laboratory application, equipping learners with the experimental skills essential to understanding drug actions through hands-on animal studies. A comprehensive, curriculum-based guide designed for second-year B. Pharm. students, fully aligned with the Pharmacy Council of India’s 2014 regulations. The book introduces students to fundamental laboratory concepts, animal handling as per CCSEA guidelines, drug administration routes, and experimental models like Rotarod, Actophotometer, and rabbit eye studies. It explores pharmacodynamic responses to various classes of drugs, including hepatic enzyme inducers, skeletal muscle relaxants, anticonvulsants, and anxiolytics. Each chapter combines clarity, precision, and ethical awareness, ensuring reproducibility and adherence to professional standards. Serving both as a laboratory manual and a learning companion, this handbook enhances analytical thinking and experimental competence, helping students gain a deeper, practice-based understanding of pharmacology. Key Features · Aligns with the PCI 2014 syllabus for second-year B. Pharm. students. · Explains fundamental experimental pharmacology concepts and instrumentation. · Demonstrates animal handling and drug administration techniques per CCSEA guidelines. · Guides pharmacodynamic testing using established models like Rotarod, Actophotometer, and MES. · Promotes laboratory competence, ethical compliance, and analytical reasoning in pharmacology

Drug Repurposing for Antivirals is a timely volume bridging pharmacology, virology, and computational science to present a cohesive understanding of the scientific and translational potential of drug repurposing in antiviral therapy with innovative strategies of finding new antiviral applications for existing drugs, an approach that shortens development timelines, reduces costs, and accelerates clinical deployment The book covers core concepts, from historical successes to modern applications in combating viral diseases. It explores computational screening, molecular docking, and AI-driven tools for identifying candidate molecules; experimental validation methods; and real-world case studies involving influenza, SARS-CoV-2, HIV, and hepatitis viruses. Special focus is given to host-targeted antivirals, broad-spectrum agents, and strategies to counter viral resistance. Regulatory aspects, challenges, and future directions for integrating repurposed antivirals into clinical practice are also discussed. Key Features: Integrates theory, methodology, and real-world case studies. Covers both computational and experimental approaches. Highlights implications for pandemic preparedness and rapid-response drug discovery. Includes contributions from leading experts in virology, medicinal chemistry, and pharmacology.

New Drugs Targeting Antibiotic-Resistant Bacteria: Recent Advances examines the molecular, pharmacological, and clinical dimensions of resistance development and highlights innovative therapeutic approaches aimed at overcoming multidrug-resistant organisms (MDROs), providing an in-depth exploration of emerging strategies to combat one of the most urgent public health challenges of our time—antimicrobial resistance (AMR). Beginning with the mechanisms underlying bacterial resistance such as β-lactamase production, efflux pump activity, and membrane protein modification, the text underscores the growing threat posed by ESKAPE pathogens and CDC-classified priority infections. Chapters also explore cutting-edge interventions including bacteriophage therapy, discovery of novel antibacterial compounds from natural sources, and the use of nanoparticles and quorum-sensing inhibitors to suppress bacterial virulence. Further sections discuss carbapenemase-mediated resistance, emphasizing enzyme classification, detection strategies, and the importance of clinical microbiology in guiding antibiotic stewardship. By integrating one-health perspectives that consider human, animal, and environmental dimensions, this book presents a holistic roadmap for addressing resistance evolution through innovation and responsible antibiotic use. Key Features Examines the molecular mechanisms driving antibiotic resistance in key bacterial species Explores bacteriophage therapy as a promising alternative to conventional antimicrobials Discovers natural-source compounds and novel drug leads for future antibiotic development Analyses carbapenemase-mediated resistance and clinical detection techniques Evaluates new therapeutic approaches including nanoparticle-based treatments and quorum-sensing inhibition Promotes the one-health approach to tackling multidrug-resistant organisms globally

Technical Advances in Pharmacy: An Overview examines the convergence of digital transformation, automation, and data intelligence in revolutionizing drug discovery, formulation, and healthcare delivery Across twelve in-depth chapters the book presents a forward-looking exploration of how emerging technologies are reshaping the landscape of pharmaceutical sciences. The book also covers cutting-edge developments such as artificial intelligence in drug discovery, pharmacogenomics and personalized medicine, blockchain in pharmaceutical supply chains, 3D printing of dosage forms, tele pharmacy, data analytics, and automation in pharmacy practice. By integrating computational modelling with experimental techniques, the text highlights the translational potential of modern technologies in enhancing drug development, patient adherence, and clinical outcomes. Serving as both a reference and a roadmap, this volume bridges traditional pharmaceutical foundations with next-generation innovations, offering readers an insightful perspective on the technological evolution shaping the future of pharmacy. Key Features Examines the role of artificial intelligence, pharmacogenomics, and data analytics in modern drug discovery. Explores blockchain, automation, and robotics as enablers of efficient and transparent pharmacy systems. Integrates computational modeling with experimental approaches for enhanced drug formulation and testing. Highlights 3D printing, telepharmacy, and RegTech as transformative tools in pharmaceutical innovation. Bridges classical pharmaceutical sciences with emerging digital and biotechnological advancements.

Presenting an advanced exploration of next-generation Field-Effect Transistor (FET) technologies, Nano-FET Devices: Miniaturisation, Simulation, and Applications (Part 2) bridges the gap between nanoscale device fundamentals and innovative real-world applications. Spanning eighteen chapters, the book focuses on Tunnel FETs (TFETs), carbon-based FETs, and biosensor innovations, charting the shift from CMOS to TFET technologies while tackling key issues of performance, scalability, and reliability. It highlights advanced architectures such as HJ-DGV-TFETs, dual-pocket step-channel TFETs, and 2D material transistors, along with metasurface photonic devices, AlGaN/GaN HEMTs, CNT-FETs, and FET-based biosensors with applications in healthcare, digital systems, and optoelectronics. Key Features Integrates multidisciplinary insights across nanotechnology, photonics, RF engineering, and bioelectronics. Analyzes advanced FET architectures and their performance optimization through simulation and modeling. Explores the role of novel nanomaterials in biosensing, memory, and optoelectronic applications. Addresses design, fabrication, and scalability challenges in nano-FET development. Identifies emerging research trends driving innovation in semiconductor and nanoelectronic technologies.

Building upon the foundational knowledge presented in Part 1, Beyond the Microscope: Nanotechnology's Impact on Our World – Part 2 explores the expanding real-world applications, regulatory considerations, and ethical implications of nanotechnology across diverse sectors. Key themes include the integration of nanomaterials in biomedical technologies, their role in sustainable agriculture and environmental remediation, as well as the development of smart materials. The book also critically examines issues surrounding toxicity, lifecycle assessments, governance frameworks, and the societal impact of emerging nanotechnologies. Chapters cover areas such as nanocarriers for drug delivery, nano-enabled food and water safety solutions, nanostructured materials for energy systems, conservation science, public perception, and policy development—offering both depth and interdisciplinary insight. Key Features: Explores advanced applications through up-to-date case studies Examines cross-sectoral impacts of nanotechnology on public health, energy, and sustainability Analyzes regulatory frameworks and safety protocols in nanomaterial usage Investigates ethical, legal, and societal issues shaping nanotech development Illustrates practical uses with visuals and applied research examples Presents future outlooks and innovation trends in global nanoscience

Beyond the Microscope: Nanotechnology’s Impact on Our World (Part 1) is an introduction to the transformative science of nanotechnology, where materials engineered at the scale of atoms are driving revolutionary advancements across disciplines. From medicine to agriculture, energy to environmental solutions, this volume provides a clear, structured, and accessible exploration of how manipulating matter at the nanoscale is reshaping the modern world. With foundational chapters covering the origins, principles, and fabrication techniques of nanomaterials, The book further explores their unique properties and the physical laws that govern nanoscale phenomena. Subsequent chapters apply these concepts across real-world contexts such as targeted drug delivery, personalized medicine, sports and fitness technologies, environmental remediation, and sustainable energy solutions. Key Features: Explains foundational principles and key milestones in nanotechnology Explores diverse nanomaterials and fabrication techniques Illustrates real-world applications in medicine, environment, energy, and sports Highlights safety, ethics, and future challenges Provides case studies to contextualize emerging technologies.

Nanotechnology in Environmental Remediation: Perspectives and Prospects details the current and emerging roles of nanotechnology in restoring environmental quality across air, water, and soil systems. Integrating recent scientific advances with practical applications, the book explores the synthesis, characterization, and deployment of nanomaterials for environmental decontamination. Divided into five parts and sixteen chapters, the book covers a wide array of topics including carbon-based and biogenic nanomaterials, biochar nanocomposites, photocatalytic technologies, and green nanotechnology. It examines applications such as wastewater treatment, air purification, soil restoration, and remediation of persistent organic pollutants. In addition to technical insights, the book addresses sustainability, safety, toxicology, and the socio-economic dimensions of nanotechnology use in environmental systems. Key features Introduces readers to green synthesis and functionalization of nanomaterials Gives an understanding of how to evaluate nanotechnology applications in air, water, and soil remediation Covers photocatalytic and sensor-based innovations Covers toxicological and environmental safety concerns Highlights future trends and sustainable practices in bioremediation

Bridging the fields of pharmacy, biotechnology, dermatology, and cosmetic science, this book offers a multidisciplinary perspective on innovation, efficacy, and safety in the development of next-generation beauty and personal care products. The book discusses emerging technologies such as nanoformulations, artificial intelligence, gene therapy, personalized medicine, and peptide science. It addresses their transformative role in cosmetic product development-from skin and hair care to sun protection, anti-aging solutions, and mood-enhancing formulations. Readers will also gain insights into regulatory frameworks, clinical studies, and intellectual property considerations, making this a practical guide for both innovation and compliance in the beauty-tech space. Key Features: Explores integration of pharmaceutical techniques in cosmetic formulation Highlights nano-carriers, AI tools, and gene-based therapies in product development Details the role of natural and herbal ingredients in modern skin and hair care Covers peptide technologies for anti-aging and skin rejuvenation Addresses personalized medicine and pharmacogenomics in cosmetics Reviews regulatory challenges, clinical validation, and patent strategies